@article{e50b5180871d46fc85c2adb1922a2587,
title = "House dust mites activate nociceptor–mast cell clusters to drive type 2 skin inflammation",
abstract = "Allergic skin diseases, such as atopic dermatitis, are clinically characterized by severe itching and type 2 immunity-associated hypersensitivity to widely distributed allergens, including those derived from house dust mites (HDMs). Here we found that HDMs with cysteine protease activity directly activated peptidergic nociceptors, which are neuropeptide-producing nociceptive sensory neurons that express the ion channel TRPV1 and Tac1, the gene encoding the precursor for the neuropeptide substance P. Intravital imaging and genetic approaches indicated that HDM-activated nociceptors drive the development of allergic skin inflammation by inducing the degranulation of mast cells contiguous to such nociceptors, through the release of substance P and the activation of the cationic molecule receptor MRGPRB2 on mast cells. These data indicate that, after exposure to HDM allergens, activation of TRPV1+Tac1+ nociceptor–MRGPRB2+ mast cell sensory clusters represents a key early event in the development of allergic skin reactions.",
author = "Nadine Serhan and Lilian Basso and Riccardo Sibilano and Camille Petitfils and James Meixiong and Chrystelle Bonnart and Reber, {Laurent L.} and Thomas Marichal and Philipp Starkl and Nicolas Cenac and Xinzhong Dong and Mindy Tsai and Galli, {Stephen J.} and Nicolas Gaudenzio",
note = "Funding Information: We thank all members of the Galli and Gaudenzio laboratories for discussions, and C. Liu for technical assistance. We thank A. Olson and the Stanford Neuroscience Microscopy Service (supported by NIH No. NS069375); this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the NIH. We thank F. L{\textquoteright}Faqihi (IFR30, Plateau Technique Cytometrie, Toulouse) and S. Allart (IFR30, Plateau Technique Imagerie Cellulaire, Toulouse) for technical assistance. T.M. is a Research Associate of the F.R.S.-FNRS and is supported by an {\textquoteleft}Incentive Grant for Scientific Research{\textquoteright} of the F.R.S.-FNRS (No. F.4508.18), by the FRFS-WELBIO under grant No. CR-2017s-04, by the Acteria Foundation and by an ERC Starting Grant (No. IM-ID 801823). P.S. acknowledges support from and the Austrian Science Fund (No. P31113-B30). L.L.R. acknowledges support from the European Commission (Marie Sklodowska-Curie Individual Fellowship No. H2020-MSCA-IF-2014 656086) and the INSERM ATIP-Avenir program. This work was supported by grants from NIH (S.J.G., grant Nos. U19 AI104209, R01 AR067145 and R01 AI32494), the United States–Israel Binational Science Foundation (No. 2013263) and the Sean N. Parker Center for Allergy and Asthma Research, Stanford University (to S.J.G.); and by the Soci{\'e}t{\'e} Fran{\c c}aise de Dermatologie, the Soci{\'e}t{\'e} Fran{\c c}aise d{\textquoteright}Allergologie, the Marie Sklodowska-Curie Individual Fellowship (H2020-MSCA-IF-2016, No. 749629), the European Research Council (ERC-2018-STG, No. 802041) and the INSERM ATIP-Avenir program (to N.G.). Publisher Copyright: {\textcopyright} 2019, The Author(s), under exclusive licence to Springer Nature America, Inc.",
year = "2019",
month = nov,
day = "1",
doi = "10.1038/s41590-019-0493-z",
language = "English (US)",
volume = "20",
pages = "1435--1443",
journal = "Nature Immunology",
issn = "1529-2908",
publisher = "Nature Publishing Group",
number = "11",
}